Trial Profile
Comparison of cyclosporine-based, twice daily tacrolimus and once daily sustained-release tacrolimus based-regimen in renal transplant recipients: A randomized, controlled, open-label, multi-centre clinical trial.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 25 Aug 2012 New trial record